TitleAssistant Professor
InstitutionMD Anderson
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thongon N, Ma F, Baran N, Lockyer P, Liu J, Jackson C, Rose A, Furudate K, Wildeman B, Marchesini M, Marchica V, Storti P, Todaro G, Ganan-Gomez I, Adema V, Rodriguez-Sevilla JJ, Qing Y, Ha MJ, Fonseca R, Stein C, Class C, Tan L, Attanasio S, Garcia-Manero G, Giuliani N, Berrios Nolasco D, Santoni A, Cerchione C, Bueso-Ramos C, Konopleva M, Lorenzi P, Takahashi K, Manasanch E, Sammarelli G, Kanagal-Shamanna R, Viale A, Chesi M, Colla S. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nat Commun. 2024 Feb 08; 15(1):1203. PMID: 38331987; PMCID: PMC10853245.
      Citations:    Fields:    Translation:HumansCells
    2. Kim J, Hurh K, Kim H, Park EC, Ha MJ. Effect of the peripartum depressive symptoms on the Internet use disorder of their offspring in late childhood: retrospective longitudinal study. Sci Rep. 2024 01 03; 14(1):417. PMID: 38172226; PMCID: PMC10764353.
      Citations:    Fields:    Translation:Humans
    3. Saridogan T, Akcakanat A, Zhao M, Evans KW, Yuca E, Scott S, Kirby BP, Zheng X, Ha MJ, Chen H, Ng PKS, DiPeri TP, Mills GB, Rodon Ahnert J, Damodaran S, Meric-Bernstam F. Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Sci Rep. 2023 11 18; 13(1):20223. PMID: 37980453; PMCID: PMC10657448.
      Citations:    Fields:    Translation:HumansAnimals
    4. Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol. 2023 Jun 06; 6(1):608. PMID: 37280434; PMCID: PMC10244399.
    5. Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol. 2023 05 11; 6(1):509. PMID: 37169941; PMCID: PMC10175489.
    6. Huang L, Long JP, Irajizad E, Doecke JD, Do KA, Ha MJ. A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes. Bioinformatics. 2023 01 01; 39(1). PMID: 36648331; PMCID: PMC9879726.
      Citations:    Fields:    Translation:Humans
    7. Huang L, Wang J, Fang B, Meric-Bernstam F, Roth JA, Ha MJ. CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts. Sci Rep. 2022 07 29; 12(1):12984. PMID: 35906256; PMCID: PMC9338066.
      Citations:    Fields:    
    8. Lee SH, Yim SY, Jeong YS, Li QX, Kang SH, Sohn BH, Kumar SV, Shin JH, Choi YR, Shim JJ, Kim H, Kim JH, Kim S, Guo S, Johnson RL, Kaseb A, Kang KJ, Chun YS, Jang HJ, Lee BG, Woo HG, Ha MJ, Akbani R, Roberts LR, Wheeler DA, Lee JS. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology. 2022 12; 76(6):1634-1648. PMID: 35349735; PMCID: PMC9519807.
      Citations:    Fields:    
    9. Ha MJ, Singareeka Raghavendra A, Kettner NM, Qiao W, Damodaran S, Layman RM, Hunt KK, Shen Y, Tripathy D, Keyomarsi K. Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study. Int J Cancer. 2022 06 15; 150(12):2025-2037. PMID: 35133007; PMCID: PMC9018572.
      Citations:    Fields:    Translation:Humans
    10. Meraz IM, Majidi M, Shao R, Meng F, Ha MJ, Shpall E, Roth JA. TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model. Commun Biol. 2022 02 24; 5(1):167. PMID: 35210547; PMCID: PMC8873264.
      Citations:    Translation:Animals
    11. Pairawan S, Akcakanat A, Kopetz S, Tapia C, Zheng X, Chen H, Ha MJ, Rizvi Y, Holla V, Wang J, Evans KW, Zhao M, Busaidy N, Fang B, Roth JA, Dumbrava EI, Meric-Bernstam F. Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248. PMID: 35075200; PMCID: PMC8786858.
      Citations:    Fields:    Translation:HumansAnimalsCells
    12. Long JP, Ha MJ. Sample Selection Bias in Evaluation of Prediction Performance of Causal Models. Stat Anal Data Min. 2022 Feb; 15(1):5-14. PMID: 35498876; PMCID: PMC9053600.
    13. Robichaux JP, Le X, Vijayan RSK, Hicks JK, Heeke S, Elamin YY, Lin HY, Udagawa H, Skoulidis F, Tran H, Varghese S, He J, Zhang F, Nilsson MB, Hu L, Poteete A, Rinsurongkawong W, Zhang X, Ren C, Liu X, Hong L, Zhang J, Diao L, Madison R, Schrock AB, Saam J, Raymond V, Fang B, Wang J, Ha MJ, Cross JB, Gray JE, Heymach JV. Structure-based classification predicts drug response in EGFR-mutant NSCLC. Nature. 2021 09; 597(7878):732-737. PMID: 34526717; PMCID: PMC8481125.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    14. Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK. Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer. Ann Surg. 2021 08 01; 274(2):e150-e159. PMID: 31436549; PMCID: PMC7031042.
      Citations: 3     Fields:    Translation:Humans
    15. Lulla AR, Akli S, Karakas C, Ha MJ, Fowlkes NW, Mitani Y, Bui T, Wang J, Rao X, Hunt KK, Meijer L, El-Naggar AK, Keyomarsi K. LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis. 2021 May 14; 10(5):40. PMID: 33990543; PMCID: PMC8121779.
    16. Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration. Cancers (Basel). 2021 Apr 01; 13(7). PMID: 33916118; PMCID: PMC8036262.
      Citations: 2     
    17. Ha MJ, Kim J, Do KA, Peterson CB, Galloway-Pe?a J. Compositional zero-inflated network estimation for microbiome data. BMC Bioinformatics. 2020 Dec 28; 21(Suppl 21):581. PMID: 33371887; PMCID: PMC7768662.
      Citations: 1     Fields:    Translation:Humans
    18. Zhang X, Zhang R, Chen H, Wang L, Ren C, Pataer A, Wu S, Meng QH, Ha MJ, Morris J, Xi Y, Wang J, Zhang J, Gibbons DL, Heymach JV, Meric-Bernstam F, Minna J, Swisher SG, Roth JA, Fang B. KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Am J Cancer Res. 2020; 10(12):4464-4475. PMID: 33415011; PMCID: PMC7783771.
      Citations: 7     
    19. Ha MJ, Sun W. Estimation of high-dimensional directed acyclic graphs with surrogate intervention. Biostatistics. 2020 10 01; 21(4):659-675. PMID: 30596892; PMCID: PMC7776804.
      Citations:    Fields:    Translation:Humans
    20. Jones RJ, Singh RK, Shirazi F, Wan J, Wang H, Wang X, Ha MJ, Baljevic M, Kuiatse I, Davis RE, Orlowski RZ. Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors. Front Immunol. 2020; 11:1816. PMID: 32903557; PMCID: PMC7438474.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    21. Ha MJ, Stingo FC, Baladandayuthapani V. Bayesian Structure Learning in Multi-layered Genomic Networks. J Am Stat Assoc. 2021; 116(534):605-618. PMID: 34239216; PMCID: PMC8259335.
      Citations: 1     
    22. Bhattacharyya R, Ha MJ, Liu Q, Akbani R, Liang H, Baladandayuthapani V. Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome. JCO Clin Cancer Inform. 2020 05; 4:399-411. PMID: 32374631; PMCID: PMC7265783.
      Citations: 4     Fields:    Translation:HumansCells
    23. Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595. PMID: 32253074; PMCID: PMC7434695.
      Citations: 7     Fields:    Translation:Humans
    24. Liu Q, Ha MJ, Bhattacharyya R, Garmire L, Baladandayuthapani V. Network-Based Matching of Patients and Targeted Therapies for Precision Oncology. Pac Symp Biocomput. 2020; 25:623-634. PMID: 31797633; PMCID: PMC7301202.
      Citations:    Fields:    Translation:HumansCells
    25. Meraz IM, Majidi M, Meng F, Shao R, Ha MJ, Neri S, Fang B, Lin SH, Tinkey PT, Shpall EJ, Morris J, Roth JA. An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses. Cancer Immunol Res. 2019 08; 7(8):1267-1279. PMID: 31186248; PMCID: PMC7213862.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    26. Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JPW, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, Karuturi MS, Watowich SS, Sahin A, Tweardy DJ, Hunt KK, Tripathy D, Keyomarsi K. Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer. Clin Cancer Res. 2019 07 01; 25(13):3996-4013. PMID: 30867218; PMCID: PMC6606366.
      Citations: 35     Fields:    Translation:HumansCells
    27. Ha MJ, Banerjee S, Akbani R, Liang H, Mills GB, Do KA, Baladandayuthapani V. Personalized Integrated Network Modeling of the Cancer Proteome Atlas. Sci Rep. 2018 10 08; 8(1):14924. PMID: 30297783; PMCID: PMC6175854.
      Citations: 3     Fields:    Translation:HumansCells
    28. Kim J, Do KA, Ha MJ, Peterson CB. Bayesian inference of hub nodes across multiple networks. Biometrics. 2019 03; 75(1):172-182. PMID: 30051914; PMCID: PMC6393214.
      Citations:    Fields:    Translation:Humans
    29. Ni Y, Stingo FC, Ha MJ, Akbani R, Baladandayuthapani V. Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics. J Am Stat Assoc. 2019; 114(525):48-60. PMID: 31178611; PMCID: PMC6552682.
      Citations: 5     
    30. Class CA, Ha MJ, Baladandayuthapani V, Do KA. iDINGO-integrative differential network analysis in genomics with Shiny application. Bioinformatics. 2018 04 01; 34(7):1243-1245. PMID: 29194470; PMCID: PMC6030922.
      Citations: 4     Fields:    Translation:Humans
    31. Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K. Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer. Clin Cancer Res. 2017 Jun 15; 23(12):2991-3002. PMID: 27881578; PMCID: PMC5441976.
      Citations: 23     Fields:    Translation:HumansCells
    32. Yang Q, Chen LS, Ha MJ, Do KA, Neelapu SS, Gandhi V. Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma. Clin Cancer Res. 2017 Jan 01; 23(1):181-192. PMID: 27342398; PMCID: PMC5433851.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    33. Ha MJ, Sun W, Xie J. PenPC: A two-step approach to estimate the skeletons of high-dimensional directed acyclic graphs. Biometrics. 2016 Mar; 72(1):146-55. PMID: 26406114; PMCID: PMC4808501.
      Citations: 10     Fields:    Translation:Humans
    34. Ha MJ, Baladandayuthapani V, Do KA. DINGO: differential network analysis in genomics. Bioinformatics. 2015 Nov 01; 31(21):3413-20. PMID: 26148744; PMCID: PMC4751246.
      Citations: 36     Fields:    Translation:HumansCells
    35. Ha MJ, Baladandayuthapani V, Do KA. Prognostic gene signature identification using causal structure learning: applications in kidney cancer. Cancer Inform. 2015; 14(Suppl 1):23-35. PMID: 25861215; PMCID: PMC4362630.
      Citations: 4     
    36. Ha MJ, Sun W. Partial correlation matrix estimation using ridge penalty followed by thresholding and re-estimation. Biometrics. 2014 Sep; 70(3):765-73. PMID: 24845967; PMCID: PMC4239206.
      Citations: 7     Fields:    Translation:Animals
    37. DINGO. Bioinformatics. 31:3413-3420.
    38. PenPC. Biometrics.
    39. Prognostic gene signature identification using causal structure learning. Cancer Informatics. 14:23-35.
    40. Partial correlation matrix estimation using ridge penalty followed by thresholding and re-estimation. Biometrics. 70:765-773.
    HA's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (173)
    Co-Authors (57)
    Similar People (60)
    Same Department Expand Description